ch3cslidesibd - incidence=6-8/100 000 all populations...

Info iconThis preview shows pages 1–11. Sign up to view the full content.

View Full Document Right Arrow Icon
MPET- IBD Inflammatory Bowel Disease v Crohn’s disease v Colitis ulcerosa Chronic inflammatory diseases with acute exacerbations
Background image of page 1

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
MPET- IBD Inflammatory Bowel Disease Crohn’s disease Well-defined segments of the bowel, from esophagus to anus with interspersed normal segments Transmural inflammation: can lead to perforation and fistulation, ulceration, damage of mucosa Repair can involve scar formation and stenosis Granulomas can be present Diarrhea, pain, fatigue and fever, weight loss
Background image of page 2
MPET- IBD Inflammatory Bowel Disease Colitis Ulcerosa Only the colon, continuous area Restricted to mucosa and submucosa Blood containing diarrhea Granulomas are not present Predisposition for colon cancer
Background image of page 3

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
MPET- IBD Inflammatory Bowel Disease Epidemiology: m.Crohn: most in Western populations (Caucasian RR2- 5, Jewish RR x5) incidence= 3/100 000 no gender preference starts mostly between age 15-35 Colitis ulcerosa:
Background image of page 4
Background image of page 5

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Background image of page 6
Background image of page 7

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Background image of page 8
Background image of page 9

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Background image of page 10
Background image of page 11
This is the end of the preview. Sign up to access the rest of the document.

Unformatted text preview: incidence=6-8/100 000 all populations Genetic predisposition MPET- IBD Inflammatory Bowel Disease Pathogenesis: v Infectious causes? v Abnormal immune reaction: IL-10-/- mice v Inflammation as a final mechanism MPET- IBD Inflammatory Bowel Disease Therapy: v anti-inflammatory drugs: sulfasalazine, glucocorticoids v anti-TNF therapy: infliximab versus etanercept Korzenik et al. Nature Reviews Drug Discovery 5 , 197–209 (March 2006) | doi:10.1038/nrd1986 Korzenik et al. Nature Reviews Drug Discovery 5 , 197–209 (March 2006) | doi:10.1038/nrd1986 Korzenik et al. Nature Reviews Drug Discovery 5 , 197–209 (March 2006) | doi:10.1038/nrd1986 Korzenik et al. Nature Reviews Drug Discovery 5 , 197–209 (March 2006) | doi:10.1038/nrd1986 Korzenik et al. Nature Reviews Drug Discovery 5 , 197–209 (March 2006) | doi:10.1038/nrd1986...
View Full Document

This note was uploaded on 05/28/2010 for the course WE BIBI000000 taught by Professor Johangrooten during the Spring '10 term at Ghent University.

Page1 / 11

ch3cslidesibd - incidence=6-8/100 000 all populations...

This preview shows document pages 1 - 11. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online